Tadataka Yamada - Net Worth and Insider Trading
Tadataka Yamada Net Worth
The estimated net worth of Tadataka Yamada is at least $4 Million dollars as of 2024-05-03. Tadataka Yamada is the Director of Agilent Technologies Inc and owns about 19,351 shares of Agilent Technologies Inc (A) stock worth over $3 Million. Tadataka Yamada is also the Director of Passage Bio Inc and owns about 656,149 shares of Passage Bio Inc (PASG) stock worth over $882,520. Details can be seen in Tadataka Yamada's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tadataka Yamada has not made any transactions after 2020-03-03 and currently still holds the listed stock(s).
Transaction Summary of Tadataka Yamada
Tadataka Yamada Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tadataka Yamada owns 6 companies in total, including Athira Pharma Inc (ATHA) , Agilent Technologies Inc (A) , and Phathom Pharmaceuticals Inc (PHAT) among others .
Click here to see the complete history of Tadataka Yamada’s form 4 insider trades.
Insider Ownership Summary of Tadataka Yamada
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATHA | Athira Pharma Inc | 2020-09-17 | director |
| A | Agilent Technologies Inc | 2014-03-20 | director |
| PHAT | Phathom Pharmaceuticals Inc | 2019-10-24 | director & 10 percent owner |
 | | 2020-03-03 | director |
| | 2021-03-11 | director & other: and Chairman of the Board |
| | 2021-07-28 | director |
Tadataka Yamada Latest Holdings Summary
Tadataka Yamada currently owns a total of 2 stocks. Among these stocks, Tadataka Yamada owns 19,351 shares of Agilent Technologies Inc (A) as of March 20, 2014, with a value of $3 Million and a weighting of 75.4%. Tadataka Yamada also owns 656,149 shares of Passage Bio Inc (PASG) as of March 3, 2020, with a value of $882,520 and a weighting of 24.6%.
Latest Holdings of Tadataka Yamada
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| A | Agilent Technologies Inc | 2014-03-20 | 19,351 | 139.75 | 2,704,302 |
| PASG | Passage Bio Inc | 2020-03-03 | 656,149 | 1.35 | 882,520 |
Holding Weightings of Tadataka Yamada
Tadataka Yamada Form 4 Trading Tracker
According to the SEC Form 4 filings, Tadataka Yamada has made a total of 0 transactions in Agilent Technologies Inc (A) over the past 5 years. The most-recent trade in Agilent Technologies Inc is the sale of 0 shares on March 20, 2014, which brought Tadataka Yamada around $0.
According to the SEC Form 4 filings, Tadataka Yamada has made a total of 1 transactions in Passage Bio Inc (PASG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Passage Bio Inc is the acquisition of 6,500 shares on March 3, 2020, which cost Tadataka Yamada around $117,000.
Insider Trading History of Tadataka Yamada
- 1
Tadataka Yamada Trading Performance
GuruFocus tracks the stock performance after each of Tadataka Yamada's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tadataka Yamada is 22.05%. GuruFocus also compares Tadataka Yamada's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tadataka Yamada within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tadataka Yamada's insider trading performs compared to the benchmark.
Performance of Tadataka Yamada
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -27.05 | | | | | |
| Relative Return to S&P 500(%) | -9.91 | | | | | |
Tadataka Yamada Ownership Network
Tadataka Yamada Owned Company Details
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
Tadataka Yamada is the director of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Vice President of Discovery Kevin Church .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, Tadataka Yamada made no insider transaction in Athira Pharma Inc (ATHA). Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,596 shares made by Andrew Gengos , a net sale of 9,640 shares made by Mark James Litton , and a net sale of 4,824 shares made by Kevin Church .
In summary, during the past 3 months, insiders sold 0 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,528 shares of Athira Pharma Inc (ATHA) were sold and 800,698 shares were bought by its insiders, resulting in a net purchase of 774,170 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
Tadataka Yamada Mailing Address
Above is the net worth, insider trading, and ownership report for Tadataka Yamada. You might contact Tadataka Yamada via mailing address: Covidien Ltd., 15 Hampshire Street, Mansfield Ma 02048.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
